G587-0375 Screening compound: 5-methyl-3-[4-(pyrimidin-2-yl)piperazine-1-carbonyl]-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxalin-6-one

G587-0375 Screening compound: 5-methyl-3-[4-(pyrimidin-2-yl)piperazine-1-carbonyl]-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxalin-6-one
G587-0375 Screening compound: 5-methyl-3-[4-(pyrimidin-2-yl)piperazine-1-carbonyl]-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxalin-6-one alternative view

Chemical Structure Depiction of ChemDiv screening compound G587-0375
5-methyl-3-[4-(pyrimidin-2-yl)piperazine-1-carbonyl]-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxalin-6-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G587-0375

Molecular Formula

C22H26N6O2 (C22 H26 N6 O2)

Compound Name

5-methyl-3-[4-(pyrimidin-2-yl)piperazine-1-carbonyl]-5H,6H,6aH,7H,8H,9H,10H-pyrido[1,2-a]quinoxalin-6-one

IUPAC name

5-methyl-3-[4-(pyrimidin-2-yl)piperazine-1-carbonyl]-5H6H6aH7H8H9H10H-pyrido[12-a]quinoxalin-6-one

SMILES

CN1c(cc(cc2)C(N(CC3)CCN3c3ncccn3)=O)c2N(CCCC2)C2C1=O

InChI

InChI=1S/C22H26N6O2/c1-25-19-15-16(6-7-17(19)28-10-3-2-5-18(28)21(25)30)20(29)26-11-13-27(14-12-26)22-23-8-4-9-24-22/h4,6-9,15,18H,2-3,5,10-14H2,1H3/t18-/m0/s1

InChI Key

BJMFXVCQKPLTOR-SFHVURJKSA-N

MDL Number (MFCD)

MFCD15021404

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

406.49

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.449

Distribution Coefficient, logD

1.449

Water Solubility, LogSw

-1.90

Polar Surface Area

56.100

Acid Dissociation Constant (pKa)

15.09

Base Dissociation Constant (pKb)

2.67

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

45.50

G587-0375 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Akt-Targeted Library (14764 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
Targets:
  • Kinases
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with G587-0375 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G587-0375?
Check Price and Availability of G587-0375, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G587-0375 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G587-0375
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G587-0375
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G587-0375 available by request